You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Drug makers, Massachusetts to form consortium

They will conduct research on neurological disorders

Massachusetts and seven pharmaceutical companies are expected to unveil an ambitious neuroscience consortium Wednesday aimed at improving the understanding and treatment of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.

Participants in the Massachusetts Neuroscience Consortium include Abbott Laboratories, Biogen Idec, Inc., EMD Serono Inc., Janssen Research & Development LLC, Merck & Co., Pfizer Inc., and Sunovion Pharmaceuticals Inc. Each has pledged $250,000, for initial funding of $1.75 million. The money will go toward preclinical neuroscience at various academic and research institutions in the state.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week